A Phase 2 Study of Atezolizumab for Pretreated NSCLC With Idiopathic Interstitial Pneumonitis
Satoshi Ikeda, Terufumi Kato, Hirotsugu Kenmotsu, Takashi Ogura, Shunichiro Iwasawa, Yuki Sato, Toshiyuki Harada, Kaoru Kubota, Takaaki Tokito, Isamu Okamoto, Naoki Furuya, Toshihide Yokoyama, Shinobu Hosokawa, Tae Iwasawa, Takeharu Yamanaka, Hiroaki Okamoto
Topics & Concepts
MedicineAtezolizumabPneumonitisInternal medicineIdiopathic pulmonary fibrosisDiscontinuationClinical endpointGastroenterologyHypersensitivity pneumonitisLung cancerLungCancerClinical trialImmunotherapyNivolumabInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisCancer Immunotherapy and BiomarkersLung Cancer Research Studies